Clinical Trial Update: Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cellular immunotherapy for immune tolerance in past recipients of HLA zero-mismatch, living-donor kidney transplants has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Snippet

Sponsor: Medeor Therapeutics, Inc. | Conditions: Kidney Transplant Rejection | Phase 2 | Status: WITHDRAWN